Abstract
Objective: To determine the safety profile of anakinra after extended exposure in a diverse clinical trial population of patients with rheumatoid arthritis. Methods: A six month, randomised, double blind phase...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have